460 related articles for article (PubMed ID: 18538829)
1. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
2. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
3. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
4. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
5. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
7. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
[TBL] [Abstract][Full Text] [Related]
8. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
9. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
[TBL] [Abstract][Full Text] [Related]
10. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
[TBL] [Abstract][Full Text] [Related]
13. Does IgA-alpha1 antitrypsin complex correlate with IgM, IgG and IgA rheumatoid factor in early rheumatoid arthritis?
Lacki JK; Hrycaj P; Klama K; Mackiewicz U; Mackiewicz SH; Muller W
Mater Med Pol; 1994; 26(3):97-100. PubMed ID: 7603085
[TBL] [Abstract][Full Text] [Related]
14. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
15. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
17. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
Neidhart M
J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
